Posterior Reversible Encephalopathy Syndrome and Azathioprine

Posterior reversible encephalopathy syndrome (PRES) is a rare syndrome that presents with neurological manifestations, often associated with arterial hypertension. Magnetic resonance imaging (MRI) shows bilateral white matter oedema in the posterior vascular territories. Immunosuppression, (pre) eclampsia and autoimmune diseases can be implicated. A 27-year-old woman, with mixed connective tissue disease under azathioprine, was admitted in the emergency room in status epilepticus and with severe hypertension. The MRI showed bilateral oedema in a pattern compatible with PRES. There was clinical improvement after azathioprine suspension. PRES is typically reversible with prompt recognition of the syndrome and its trigger. The association with azathioprine is rare. LEARNING POINTS: Posterior reversible encephalopathy syndrome should be considered in patients with sudden onset of headache, altered consciousness and seizures.Recognition of this entity and identification of the trigger are essential for reversal of the clinical picture.Autoimmune diseases and some immunosuppressive drugs have been identified as causative, but reports of an association with azathioprine are very rare.info:eu-repo/semantics/publishedVersio

Modern estates and the production of Lisbon’s suburbs: From the planned to the lived neighbourhood

Alto da Barra and Portela are two modern estates designed by the same architect and located on two sides of the periphery of Lisbon: the west side, Costa do Sol, where the river meets the Atlantic and the east, with no label, which is upstream. The estates were planned and built in the same period (1960s to 1970s), the height of Lisbon’s urban development. This article presents a comparative analysis of these estates: their plans, implementation, social appropriation and resilience, by exploring the sociological profile and place-attachment perceptions of their inhabitants. The analysis also contextualises the development of the estates within the consolidation of these two quite different Lisbon peripheries: the west side traditionally highly valued in relation to the east. An intensive methodology was developed—case studies of the two estates—combining quantitative (survey, inter-census analysis) and qualitative (interviews and documentary analysis) methods. In addition to the differences between the two estates, which were largely due to their specificities in terms of geographic location and status, both reveal significant feelings of place-attachment and a rejection of the suburbia label.info:eu-repo/semantics/publishedVersio

Salvage Flexor Hallucis Longus Transfer for a Failed Achilles Repair: Endoscopic Technique

Flexor hallucis longus (FHL) transfer is a well-established treatment option in failed Achilles tendon (AT) repair and has been routinely performed as an open procedure. We detail the surgical steps needed to perform an arthroscopic transfer of the FHL for a chronic AT rupture. The FHL tendon is harvested as it enters in its tunnel beneath the sustentaculum tali; a tunnel is then drilled in the calcaneus as near to the AT footprint as possible. By use of a suture-passing device, the free end of the FHL is advanced to the plantar aspect of the foot. After adequate tension is applied to the construct, the tendon is fixed in place with an interference screw in an inside-out fashion. This minimally invasive approach is a safe and valid alternative to classic open procedures with the obvious advantages of preserving the soft-tissue envelope and using a biologically intact tendon

Influencia del contenido de OHAP y de gentamicina en la liberación del antibiótico a partir de composites de OHAP/PEMMA

El objetivo de este trabajo fue estudiar la influencia del contenido de hidroxiapatita (OHAp) y de sulfato de gentamicina (SG) en la velocidad de liberación de dicho antibiótico a partir de materiales compuestos por OHAp, polimetacrilato de metilo (PMMA) y polimetacrilato de etilo (PEMA). Para ello se prepararon muestras con diferente proporción de OHAp (30 y 40%) y de SG (5 y 10%). El estudio de liberación se llevó a cabo sumergiendo 3 muestras de cada grupo en SBF a 37°C, el medio fue renovado a diferentes intervalos de tiempo durante 70 días. La concentración de gentamicina fue determinada por el método del o-ftaldialdehído. Los resultados del estudio de liberación mostraron, que la liberación ocurre de manera más rápida durante las primeras 10 horas de inmersión en SBF y que posteriormente se hace más lenta. Se observó que las muestras con un mayor tanto por ciento (40%) de OHAp liberan mayor cantidad de antibiótico. Las muestras con un 40% de OHAp liberaron el 100% de SG a los 70 días, mientras que en ese mismo período las muestras con 30% de OHAp liberaron un 85%. Por otra parte, se observó que la cantidad de gentamicina añadida inicialmente no afecta el tanto por ciento de SG que se libera.Peer Reviewe

Synthesis and coordination chemistry of 2-(di-2-pyridylamino)pyrimidine; structural aspects of spin crossover in an Fe(II) complex

This paper was accepted on February 26 20122-(Di-2-pyridylamino)pyrimidine (L), a potentially ditopic tetradentate ligand, was synthesized from commercially available di-2-pyridylamine and 2-chloropyrimidine. Despite being capable of bridging two metal atoms with bidentate chelation of both metal centres, L prefers to chelate or bridge through the more basic pyridyl donors of the di-2-pyridylamine moiety. Mononuclear trans-[Fe(NCS)2(L)2] and [Cu(L)2(H2O)](BF4)2•H2O complexes, and a discrete [Ag2(L)4](PF6)2 metallomacrocycle were isolated and structurally characterized by X-ray crystallography. A mononuclear palladium complex [PdCl2(L)]•(solvate), where solvate = ½H2O or CH2Cl2, was also readily obtained in 71% yield. One example of the ligand acting as a bis(bidentate) bridging ligand was observed in a dinuclear [(PdCl2)2(L)]•¾H2O complex that was obtained only in very low yield (ca. 3%) from the reaction that produced [PdCl2(L)]•½H2O. trans-[Fe(NCS)2(L)2] undergoes a temperature dependent HS-LS (HS = high spin; LS = low spin) crossover at ca. 205 K that was 2 observed by X-ray crystallography and magnetic measurements and attempts were made to understand the structural basis of this process. Despite efforts to isolate examples of L bridging two iron(II) centres, only the mononuclear trans-[Fe(NCS)2(L)2] species could be obtained.Rachel S. Crees, Boujemma Moubaraki, Keith S. Murray, and Christopher J. Sumb

Trigger and readout electronics for the STEREO experiment

The STEREO experiment will search for a sterile neutrino by measuring the anti-neutrino energy spectrum as a function of the distance from the source, the ILL nuclear reactor. A dedicated electronic system, hosted in a single microTCA crate, was designed for this experiment. It performs triggering in two stages with various selectable conditions, processing and readout via UDP/IPBUS of 68 photomultiplier signals continuously digitized at 250 MSPS. Additionally, for detector performance monitoring, the electronics allow on-line calibration by driving LED synchronously with the data acquisition. This paper describes the electronics requirements, architecture and the performances achieved.Comment: Topical Workshop on Electronics for Particle Physics (TWEPP) 2015, Lisboa. 9 pages, 9 figure

Low-level laser therapy in neurosensory recovery : case series in dental and maxillofacial rehabilitation

Abstract in proceedings of the Fourth International Congress of CiiEM: Health, Well-Being and Ageing in the 21st Century, held at Egas Moniz’ University Campus in Monte de Caparica, Almada, from 3–5 June 2019.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.info:eu-repo/semantics/publishedVersio

Use of data description languages in the interchange of data

The Consultative Committee for Space Data Systems (CCSDS) is developing Standards for the interchange of information between systems, including those operating under different environments. The objective is to perform the interchange automatically, i.e. in a computer interpretable manner. One aspect of the concept developed by CCSDS is the use of a separate data description to specify the data being transferred. Using the description, data can then be automatically parsed by the receiving computer. With a suitably expressive Data Description Language (DDL), data formats of arbitrary complexity can be handled. The advantages of this approach are: (1) that the description need only be written and distributed once to all users, and (2) new software does not need to be written for each new format, provided generic tools are available to support writing and interpretation of descriptions and the associated data instances. Consequently, the effort of 'hard coding' each new format is avoided and problems of integrating multiple implementations of a given format by different users are avoided. The approach is applicable in any context where computer parsable description of data could enhance efficiency (e.g. within a spacecraft control system, a data delivery system or an archive). The CCSDS have identified several candidate DDL's: EAST (Extended Ada Subset), TSDN (Transfer Syntax Data Notation) and MADEL (Modified ASN.1 as a Data Description Language -- a DDL based on the Abstract Syntax Notation One - ASN.1 - specified in the ISO/IEC 8824). This paper concentrates on ESA's development of MADEL. ESA have also developed a 'proof of concept' prototype of the required support tools, implemented on a PC under MS-DOS, which has successfully demonstrated the feasibility of the approach, including the capability within an application of retrieving and displaying particular data elements, given its MADEL description (i.e. a data description written in MADEL). This paper outlines the work done to date and assesses the applicability of this modified ASN.1 as a DDL. The feasibility of the approach is illustrated with several examples

Cyclooxygenase-2 Expression in Bladder Cancer and Patient Prognosis: Results from a Large Clinical Cohort and Meta-Analysis

Aberrant overexpression of cyclooxygenase-2 (COX2) is observed in urothelial carcinoma of the bladder (UCB). Studies evaluating COX2 as a prognostic marker in UCB report contradictory results. We determined the prognostic potential of COX2 expression in UCB and quantitatively summarize the results with those of the literature through a meta-analysis. Newly diagnosed UCB patients recruited between 1998–2001 in 18 Spanish hospitals were prospectively included in the study and followed-up (median, 70.7 months). Diagnostic slides were reviewed and uniformly classified by expert pathologists. Clinical data was retrieved from hospital charts. Tissue microarrays containing non-muscle invasive (n = 557) and muscle invasive (n = 216) tumours were analyzed by immunohistochemistry using quantitative image analysis. Expression was evaluated in Cox regression models to assess the risk of recurrence, progression and disease-specific mortality. Meta-hazard ratios were estimated using our results and those from 11 additional evaluable studies. COX2 expression was observed in 38% (211/557) of non-muscle invasive and 63% (137/216) of muscle invasive tumors. Expression was associated with advanced pathological stage and grade (p<0.0001). In the univariable analyses, COX2 expression - as a categorical variable - was not associated with any of the outcomes analyzed. As a continuous variable, a weak association with recurrence in non-muscle invasive tumors was observed (p-value = 0.048). In the multivariable analyses, COX2 expression did not independently predict any of the considered outcomes. The meta-analysis confirmed these results. We did not find evidence that COX2 expression is an independent prognostic marker of recurrence, progression or survival in patients with UCB.The work was partially supported by the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain (G03/174, 00/0745, PI051436, PI061614 and G03/174); Red Temática de Investigación Cooperativa en Cáncer- RD06/0020-RTICC; Consolider ONCOBIO; EU-FP6-STREP-37739-DRoP-ToP; EU-FP7-HEALTH-F2-2008-201663-UROMOL; EU-FP7-HEALTH-F2-2008-201333-DECanBio; USA-NIH-RO1-CA089715; and a PhD fellowship awarded to MJC from the ‘‘la Caixa’’ foundation, Spain, and a postdoctoral fellowship awarded to AFSA from the Fundación Científica de la AEC